
Immuron Limited IMRN
$ 0.8
-3.02%
Annual report 2022
added 09-09-2022
Immuron Limited DIO Ratio 2011-2026 | IMRN
Annual DIO Ratio Immuron Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.32 K | 2.33 K | 2.53 K | - | - | - | - | - | - |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.53 K | 1.32 K | 2.06 K |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
174 | - | 5743.5 % | $ 69.7 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Exelixis
EXEL
|
96.1 | $ 48.16 | 4.22 % | $ 13.1 B | ||
|
Fortress Biotech
FBIO
|
210 | $ 2.39 | -0.42 % | $ 66.7 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
295 | $ 22.4 | -0.71 % | $ 3.71 B | ||
|
Esperion Therapeutics
ESPR
|
2.46 K | $ 3.14 | - | $ 653 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Gilead Sciences
GILD
|
102 | $ 131.33 | -2.04 % | $ 163 B | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 21.17 | 2.47 % | $ 2.69 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 8.1 | 0.5 % | $ 5.51 B | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.57 | -2.48 % | $ 418 M |